⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19850415 | 0.79 | — | — | |
| SCHEMBL20470426 | 0.77 | SLC22A2 (0.35) | — | |
| SCHEMBL24254829 | 0.62 | — | — | |
| SCHEMBL25910738 | 0.59 | — | — | |
| SCHEMBL24254902 | 0.57 | — | — | |
| SCHEMBL19355051 | 0.54 | — | — | |
| SCHEMBL20245083 | 0.52 | GRIN1 (0.71) | — | |
| SCHEMBL25013437 | 0.52 | — | — | |
| SCHEMBL10702489 | 0.51 | GRIN2D (0.39) | — | |
| SCHEMBL12093018 | 0.51 | LMNA (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11697715-B2 | Cucurbituril-based hydrogels | SCHERMAN OREN (GB) | 2023-07-11 | — | — | US | disclosed |
| US-20230147129-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIES | UNIVERSITAT AUTÒNOMA DE BARCELONA (ES) | 2023-05-11 | — | — | US | disclosed |
| US-20220411591-A1 | CUCURBITURIL-BASED HYDROGELS | SCHERMAN OREN (GB) | 2022-12-29 | — | — | US | disclosed |
| US-20210322308-A1 | NOVEL PHARMACEUTICAL FORMULATIONS | AUSPEX PHARMACEUTICALS, INC. | 2021-10-21 | — | — | US | disclosed |
| WO-2017214680-A1 | ADAMANTANE COMPOUNDS | THE UNIVERSITY OF SYDNEY (AU) | 2017-12-21 | — | — | WO | disclosed |